# Adimab

Source: https://onco.cc/companies/adimab/  
OnCo record `adimab` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Adimab discovers and engineers antibodies for drug developers, including partners developing cancer medicines.

## Summary

Adimab is an antibody discovery and engineering company. Ono Pharmaceutical announced a collaboration with Adimab to discover and develop antibody drugs in oncology. The agreement covers discovery against targets selected by Ono; Ono will evaluate and develop candidates and has an option to obtain exclusive rights to develop, manufacture and commercialise them worldwide. This is a research partnership, not evidence that an antibody from it improves cancer outcomes.

## Fields

- Kind: Company
- Last checked: 2026-11-06
- HQ: Lebanon, NH
- Type: biotech
- Website: https://adimab.com/

## Notes

- Location is stated in Ono's announcement.

## Sources

- Ono oncology antibody collaboration: https://www.ono-pharma.com/en/news/20230927.html
- Official location evidence: https://www.ono-pharma.com/en/news/20230927.html
- Elicit AI for Pharma market map: https://elicit.com/ai-for-pharma

## Connected records

- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- collections: [Elicit AI for Pharma market map](https://onco.cc/collections/elicit-ai-for-pharma/)

---
JSON: https://onco.cc/api/v1/entities/adimab.json